BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Feb 06, 14:02Prev. Close
23.03
Open Price
22.30
Bid Price (Qty.)
22.89 (25)
Offer Price (Qty.)
22.90 (500)
| Key Financial Ratios of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.54 | -2.32 | 45.81 | 47.66 | 38.14 | |
| Diluted EPS (Rs.) | 4.54 | -2.31 | 45.40 | 47.66 | 38.14 | |
| Cash EPS (Rs.) | 4.88 | -0.26 | 46.87 | 48.17 | 38.44 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 41.98 | 184.77 | 179.62 | 113.16 | 64.98 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 41.98 | 184.77 | 179.62 | 113.16 | 64.98 | |
| Revenue from Operations/Share (Rs.) | 52.99 | 221.42 | 330.44 | 279.39 | 231.33 | |
| PBDIT/Share (Rs.) | 6.07 | 40.45 | 58.12 | 55.18 | 44.64 | |
| PBIT/Share (Rs.) | 5.72 | 38.53 | 56.40 | 54.66 | 44.34 | |
| PBT/Share (Rs.) | 5.19 | 1.85 | 55.91 | 54.52 | 44.33 | |
| Net Profit/Share (Rs.) | 4.54 | -2.19 | 45.14 | 47.66 | 38.14 | |
| NP After MI And SOA / Share (Rs.) | 4.54 | -2.19 | 45.14 | 47.66 | 38.14 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.45 | 18.26 | 17.58 | 19.74 | 19.29 | |
| PBIT Margin (%) | 10.80 | 17.40 | 17.06 | 19.56 | 19.16 | |
| PBT Margin (%) | 9.79 | 0.83 | 16.91 | 19.51 | 19.16 | |
| Net Profit Margin (%) | 8.56 | -0.98 | 13.66 | 17.05 | 16.48 | |
| NP After MI And SOA Margin (%) | 8.56 | -0.98 | 13.66 | 17.05 | 16.48 | |
| Return on Networth/Equity (%) | 10.81 | -1.18 | 25.13 | 42.11 | 58.69 | |
| Return on Capital Employed (%) | 12.35 | 20.56 | 30.78 | 48.28 | 68.23 | |
| Return on Assets (%) | 8.07 | -0.92 | 19.17 | 27.00 | 38.25 | |
| Total Debt/Equity (X) | 0.22 | 0.09 | 0.06 | 0.03 | 0.06 | |
| Asset Turnover Ratio (%) | 1.03 | 0.97 | 1.62 | 2.02 | 3.41 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.45 | 3.88 | 3.64 | 2.23 | 2.70 | |
| Quick Ratio (X) | 3.01 | 2.36 | 1.67 | 0.67 | 2.31 | |
| Inventory Turnover Ratio (X) | 3.64 | 1.37 | 1.99 | 3.48 | 23.83 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 1.08 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 1.04 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 98.92 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 98.96 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 11.42 | 26.29 | 118.35 | 389.66 | 3,407.65 | |
| Interest Coverage Ratios (Post Tax) (%) | 11.42 | 26.29 | 118.35 | 389.66 | 3,407.65 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 365.11 | 495.85 | 523.37 | 348.05 | 526.49 | |
| EV/Net Operating Revenue (X) | 1.25 | 2.05 | 1.56 | 1.25 | 2.28 | |
| EV/EBITDA (X) | 10.90 | 11.25 | 8.84 | 6.31 | 11.79 | |
| MarketCap/Net Operating Revenue (X) | 1.21 | 2.24 | 1.60 | 1.26 | 2.27 | |
| Retention Ratios (%) | 0.00 | 0.00 | 98.91 | 0.00 | 0.00 | |
| Price/BV (X) | 1.52 | 2.68 | 2.95 | 3.11 | 8.07 | |
| Price/Net Operating Revenue | 1.21 | 2.24 | 1.60 | 1.26 | 2.27 | |
| Earnings Yield | 0.07 | 0.00 | 0.09 | 0.14 | 0.07 |
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016